loading page

Urticaria Patients Are Highly Interested in Apps to Monitor Their Disease Activity and Control: A UCARE CURICT Analysis
  • +34
  • Ivan Cherrez-Ojeda,
  • Emanuel Vanegas,
  • Annia Cherrez,
  • Miguel Felix,
  • Karsten Weller,
  • Markus Magerl,
  • Rasmus Maurer,
  • Valeria L MATA,
  • Alicja Kasperska-Zając,
  • Agnieszka SIKORA,
  • Daria Fomina,
  • Elena KOVALKOVA,
  • Kiran Godse,
  • Nimmagadda Dheeraj RAO,
  • Maryam Khoshkhui,
  • Sahar RASTGOO,
  • Roberta Criado,
  • Mohamed Abuzakouk,
  • Deepa GRANDON,
  • Martijn van Doorn,
  • Solange Valle,
  • Eduardo M. de Souza Lima,
  • Simon Francis Thomsen,
  • German Ramón,
  • Edgar Matos E BENAVIDES,
  • Andrea Bauer,
  • Ana Giménez Arnau,
  • Emek Kocatürk,
  • Carole Guillet,
  • Jose Ignacio Larco,
  • Zuotao Zhao,
  • Michael Makris,
  • Carla RITCHIE,
  • PARASKEVI XEPAPADAKI,
  • Luis Ensina,
  • Sofia CHERREZ,
  • Marcus Maurer
Ivan Cherrez-Ojeda
Universidad Espíritu Santo Samborondón Ecuador

Corresponding Author:ivancherrez@gmail.com

Author Profile
Emanuel Vanegas
Universidad Espíritu Santo Samborondón Ecuador
Author Profile
Annia Cherrez
Respiralab Respiralab Research Group Guayaquil Ecuador
Author Profile
Miguel Felix
Universidad Espíritu Santo Samborondón Ecuador
Author Profile
Karsten Weller
Dermatological Allergology Allergie-Centrum-Charité Department of Dermatology and Allergy Charité - Universitätsmedizin Berlin Germany
Author Profile
Markus Magerl
Dermatological Allergology Allergie-Centrum-Charité Department of Dermatology and Allergy Charité - Universitätsmedizin Berlin Germany
Author Profile
Rasmus Maurer
Dermatological Allergology Allergie-Centrum-Charité Department of Dermatology and Allergy Charité - Universitätsmedizin Berlin Germany
Author Profile
Valeria L MATA
Universidad Espíritu Santo Samborondón Ecuador
Author Profile
Alicja Kasperska-Zając
European Center for Diagnosis and Treatment of Urticaria Medical University of Silesia Katowice Poland
Author Profile
Agnieszka SIKORA
European Center for Diagnosis and Treatment of Urticaria Medical University of Silesia Katowice Poland
Author Profile
Daria Fomina
City Center of Allergy and Immunology Clinical City Hospital #52 Moscow Russia
Author Profile
Elena KOVALKOVA
City Center of Allergy and Immunology Clinical City Hospital #52 Moscow Russia
Author Profile
Kiran Godse
Department of Dermatology D Y Patil University School of Medicine and Hospital Mumbai India
Author Profile
Nimmagadda Dheeraj RAO
Department of Dermatology D Y Patil University School of Medicine and Hospital Mumbai India
Author Profile
Maryam Khoshkhui
Allergy Research Center Mashhad University of Medical Sciences Mashhad Iran
Author Profile
Sahar RASTGOO
Department of Allergy and Immunology Mashhad University of Medical Sciences Mashhad Iran
Author Profile
Roberta Criado
Department of Dermatology Faculdade de Medicina do ABC São Paulo Brazil
Author Profile
Mohamed Abuzakouk
Allergy and Immunology Department Cleveland Clinic Abu Dhabi the UAE
Author Profile
Deepa GRANDON
Allergy and Immunology Department Cleveland Clinic Abu Dhabi the UAE
Author Profile
Martijn van Doorn
Department of Dermatology Erasmus MC Rotterdam The Netherlands
Author Profile
Solange Valle
Department of Internal Medicine Hospital Universitário Clementino Fraga Filho Rio de Janeiro Brazil
Author Profile
Eduardo M. de Souza Lima
Faculty of Science and Health of Juiz de Fora - SUPREMA - Minas Gerais
Author Profile
Simon Francis Thomsen
Department of Dermatology Bispebjerg Hospital University of Copenhagen Biomedical Sciences Copenhagen Denmark
Author Profile
German Ramón
Instituto de Alergia e Inmunología del Sur Bahía Blanca Prov De Buenos Aires Argentina
Author Profile
Edgar Matos E BENAVIDES
Centro de Referencia de Alergia Asma e Inmunología - Instituto Nacional del Niño Lima-Perú
Author Profile
Andrea Bauer
Department of Dermatology University Allergy Center University Hospital Carl Gustav Carus Technical University Dresden Germany
Author Profile
Ana Giménez Arnau
Department of Dermatology Hospital del Mar IMIM Universitat Autònoma Barcelona Spain
Author Profile
Emek Kocatürk
Department of Dermatology Koç University School of Medicine Istanbul Turkey
Author Profile
Carole Guillet
Department of Dermatology University Hospital Zurich Switzerland
Author Profile
Jose Ignacio Larco
Allergy Department Clinica San Felipe Lima Peru
Author Profile
Zuotao Zhao
Department of Dermatology and Venereology Peking University First Hospital Beijing China
Author Profile
Michael Makris
Allergy Unit 2nd Department of Dermatology and Venereology National and Kapodistrian University of Athens “Attikon” University Hospital Greece
Author Profile
Carla RITCHIE
Allergy Division Hospital Italiano de Buenos Aires Buenos Aires Argentina
Author Profile
PARASKEVI XEPAPADAKI
Allergy Department 2nd Pediatric Clinic National and Kapodistrian University of Athens Greece
Author Profile
Luis Ensina
Federal University of São Paulo São Paulo Brazil
Author Profile
Sofia CHERREZ
Respiralab Respiralab Research Group Guayaquil Ecuador
Author Profile
Marcus Maurer
Dermatological Allergology Allergie-Centrum-Charité Department of Dermatology and Allergy Charité - Universitätsmedizin Berlin Germany
Author Profile

Abstract

Background: Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self-evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global paucity of such apps for patients with CU. In this analysis, we assessed patient interest in using apps to monitor CU disease activity and control using questions from the CURICT study, Methods: The methodology for CURICT has been reported. Briefly, a 23-item questionnaire was completed by 1,841 CU patients from 17 UCAREs across 17 countries. Here, we analyzed patient responses to the CURICT questions on the use of apps for urticaria-related purposes. Results: As previously published, the majority of respondents had chronic spontaneous urticaria (CSU; 63%; 18% chronic inducible urticaria [CIndu]; 19% with both), were female (70%) and in urban areas (75%). Over half of patients were very/extremely interested in an app to monitor disease activity (51%) and control (53%), while only ~1/10 were not. Patients with both urticaria types vs those with CSU only (OR, 1.36 [1.03-1.79]) and females vs males (OR[95%CI], 1.47 [1.17-1.85]) were more likely to be very to extremely interested in an app to assess disease control. Conclusions: Overall, patients with CU were highly interested in using an app to assess their disease activity and control. Development of well-designed apps, specific to disease types (CSU, CIndU, CSU+CIndU, etc), validated by experts across platforms would help improve the management and possibly outcomes of CU treatment while providing important patient information to be used in future research.